Literature DB >> 21617915

Genetic testing in renal disease.

Detlef Bockenhauer1, Alan J Medlar, Emma Ashton, Robert Kleta, Nick Lench.   

Abstract

A revolution is happening in genetics! The decoding of the first genome in 2003 was a large international collaborative effort that took about 13 years at a cost of around $2.7 billion. Now, only a few years later, new technology allows the sequencing of an entire genome within a few weeks--and at a cost of less than $10,000. The vaunted $1000 genome is within reach. These extraordinary advances will undoubtedly transform the way we practice medicine. But, like any new technology, it carries risks, as well as benefits. As physicians, we need to understand the implications in order to best utilise these advances for our patients and to provide informed advice. In this review, our aim is to explain these new technologies, to separate the hype from the reality and to address some of the resulting questions and implications. The practical objective is to provide a simple overview of the available technologies and of purpose to which they are best suited.

Entities:  

Mesh:

Year:  2011        PMID: 21617915     DOI: 10.1007/s00467-011-1865-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  56 in total

Review 1.  First NIH/Office of Rare Diseases Conference on Cystinosis: past, present, and future.

Authors:  Robert Kleta; Frederick Kaskel; Ranjan Dohil; Paul Goodyer; Lisa M Guay-Woodford; Erik Harms; Julie R Ingelfinger; Vera H Koch; Craig B Langman; Mary B Leonard; Roslyn B Mannon; Minnie Sarwal; Jerry A Schneider; Flemming Skovby; Barbara C Sonies; Jess G Thoene; Doris A Trauner; William A Gahl
Journal:  Pediatr Nephrol       Date:  2005-01-27       Impact factor: 3.714

2.  Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.

Authors:  Daniel Moreno-De-Luca; Jennifer G Mulle; Erin B Kaminsky; Stephan J Sanders; Scott M Myers; Margaret P Adam; Amy T Pakula; Nancy J Eisenhauer; Kim Uhas; LuAnn Weik; Lisa Guy; Melanie E Care; Chantal F Morel; Charlotte Boni; Bonnie Anne Salbert; Ashadeep Chandrareddy; Laurie A Demmer; Eva W C Chow; Urvashi Surti; Swaroop Aradhya; Diane L Pickering; Denae M Golden; Warren G Sanger; Emily Aston; Arthur R Brothman; Troy J Gliem; Erik C Thorland; Todd Ackley; Ram Iyer; Shuwen Huang; John C Barber; John A Crolla; Stephen T Warren; Christa L Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-11-04       Impact factor: 11.025

Review 3.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Authors:  Barry I Freedman; Jeffrey B Kopp; Carl D Langefeld; Giulio Genovese; David J Friedman; George W Nelson; Cheryl A Winkler; Donald W Bowden; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

4.  Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.

Authors:  Debbie S Gipson; Howard Trachtman; Frederick J Kaskel; Milena K Radeva; Jennifer Gassman; Tom H Greene; Marva M Moxey-Mims; Ronald J Hogg; Sandra L Watkins; Richard N Fine; John P Middleton; V M Vehaskari; Susan L Hogan; Suzzane Vento; Patti A Flynn; Leslie M Powell; June L McMahan; Norman Siegel; Aaron L Friedman
Journal:  Kidney Int       Date:  2010-12-22       Impact factor: 10.612

5.  Unusual clinical presentation and possible rescue of a novel claudin-16 mutation.

Authors:  Dominik Müller; P Jaya Kausalya; Detlef Bockenhauer; Julia Thumfart; Iwan C Meij; Michael J Dillon; William van't Hoff; Walter Hunziker
Journal:  J Clin Endocrinol Metab       Date:  2006-05-16       Impact factor: 5.958

6.  Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

Authors:  Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

7.  Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects.

Authors:  Marie E Egan; Marilyn Pearson; Scott A Weiner; Vanathy Rajendran; Daniel Rubin; Judith Glöckner-Pagel; Susan Canny; Kai Du; Gergely L Lukacs; Michael J Caplan
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

Review 8.  K-ras mutations in colorectal cancer: a practice changing discovery.

Authors:  M Wasif Saif; Manasi Shah
Journal:  Clin Adv Hematol Oncol       Date:  2009-01

9.  Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.

Authors:  Robert Kleta; Elisa Romeo; Zorica Ristic; Toshihiro Ohura; Caroline Stuart; Mauricio Arcos-Burgos; Mital H Dave; Carsten A Wagner; Simone R M Camargo; Sumiko Inoue; Norio Matsuura; Amanda Helip-Wooley; Detlef Bockenhauer; Richard Warth; Isa Bernardini; Gepke Visser; Thomas Eggermann; Philip Lee; Arthit Chairoungdua; Promsuk Jutabha; Ellappan Babu; Sirinun Nilwarangkoon; Naohiko Anzai; Yoshikatsu Kanai; Francois Verrey; William A Gahl; Akio Koizumi
Journal:  Nat Genet       Date:  2004-08-01       Impact factor: 38.330

10.  Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Eric Carpentier; Driss Rochdi; W van't Hoff; Billy Breton; Virginie Bernier; Michel Bouvier; Daniel G Bichet
Journal:  Nephron Physiol       Date:  2009-10-08
View more
  25 in total

Review 1.  The molecular basis of blood pressure variation.

Authors:  Hakan R Toka; Jacob M Koshy; Ali Hariri
Journal:  Pediatr Nephrol       Date:  2012-07-05       Impact factor: 3.714

Review 2.  The blind kidney: disorders affecting kidneys and eyes.

Authors:  Isabelle Russell-Eggitt; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

3.  APOL1 variants and kidney disease in people of recent African ancestry.

Authors:  Giulio Genovese; David J Friedman; Martin R Pollak
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

4.  NPHS2 homozygous p.R229Q variant: potential modifier instead of causal effect in focal segmental glomerulosclerosis.

Authors:  Andrea Kerti; Rózsa Csohány; László Wagner; Eszter Jávorszky; Erika Maka; Kálmán Tory
Journal:  Pediatr Nephrol       Date:  2013-06-26       Impact factor: 3.714

Review 5.  The nephrologist of tomorrow: towards a kidney-omic future.

Authors:  Mina H Hanna; Alessandra Dalla Gassa; Gert Mayer; Gianluigi Zaza; Patrick D Brophy; Loreto Gesualdo; Francesco Pesce
Journal:  Pediatr Nephrol       Date:  2016-03-09       Impact factor: 3.714

Review 6.  Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus.

Authors:  Detlef Bockenhauer; Daniel G Bichet
Journal:  Nat Rev Nephrol       Date:  2015-06-16       Impact factor: 28.314

7.  Genetic Identification of Two Novel Loci Associated with Steroid-Sensitive Nephrotic Syndrome.

Authors:  Stephanie Dufek; Chris Cheshire; Adam P Levine; Richard S Trompeter; Naomi Issler; Matthew Stubbs; Monika Mozere; Sanjana Gupta; Enriko Klootwijk; Vaksha Patel; Daljit Hothi; Aoife Waters; Hazel Webb; Kjell Tullus; Lucy Jenkins; Lighta Godinho; Elena Levtchenko; Jack Wetzels; Nine Knoers; Nynke Teeninga; Jeroen Nauta; Mohamed Shalaby; Sherif Eldesoky; Jameela A Kari; Shenal Thalgahagoda; Randula Ranawaka; Asiri Abeyagunawardena; Adebowale Adeyemo; Mark Kristiansen; Rasheed Gbadegesin; Nicholas J Webb; Daniel P Gale; Horia C Stanescu; Robert Kleta; Detlef Bockenhauer
Journal:  J Am Soc Nephrol       Date:  2019-07-01       Impact factor: 10.121

8.  Over- or underfill: not all nephrotic states are created equal.

Authors:  Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2013-03-26       Impact factor: 3.714

Review 9.  Pediatric renal diseases in the Kingdom of Saudi Arabia.

Authors:  Jameela Abdulaziz Kari
Journal:  World J Pediatr       Date:  2012-08-12       Impact factor: 2.764

Review 10.  DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome.

Authors:  Judy Savige; Elisabet Ars; Richard G H Cotton; David Crockett; Hayat Dagher; Constantinos Deltas; Jie Ding; Frances Flinter; Genevieve Pont-Kingdon; Nizar Smaoui; Roser Torra; Helen Storey
Journal:  Pediatr Nephrol       Date:  2013-05-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.